Gynecology - Contemporary OB/GYN

ADVERTISEMENT

Gynecology
  • Editorial: Our not-so-not-for-profit hospitals




    Are 'Not-for-Profits' providing a reasonable level of defined community benefits?

    FDA warns of severe musculoskeletal pain months or years after taking bisphosphonates


    Patients taking bisphosphonates may develop severe and sometimes incapacitating musculoskeletal pain.

    Nonhormonal hope for vasomotor symptoms?


    Desvenlafaxine succinate, a serotonin norepinephrine reuptake inhibitor (SNRI), reduces hot flashes by about 64% after 3 months of use, according to the results of a double-blind, placebo-controlled trial.

    Adenomyosis: More common than you think



    With no clear-cut set of signs and symptoms to advertise its presence, experts suggest diagnosis may require MRI, transvaginal U/S, and/or needle biopsy. Among your treatment options: hysterectomy, GnRH agonists, and the levonorgestrel IUD.

    Endometrial cancer is seldom staged correctly


    Almost half of all original pathology reports that analyzed tissue to confirm endometrial cancer contain significant discrepancies, when compared with formal pathology reviews.

    Preeclampsia and CV risk: Which is the chicken and which is the egg?


    Consider a history of preeclampsia when calculating your patients' risk for cardiovascular disease.

    Women treated for CIN3 face long-term Ca risks


    Women who have been treated for cervical intraepithelial neoplasia grade 3 (CIN3) remain at increased risk for cervical and vaginal cancers as much as 25 years after treatment and should continue to be screened beyond current age recommendations for the general population.

    Antibiotics sharply reduce vaginal GBS


    Vaginal group B streptococcus (GBS) colony counts fall quickly and dramatically with intrapartum doses of penicillin-G.

    Postmenopausal hormone therapy cuts lung cancer risk


    Postmenopausal women who've taken hormone therapy have a lower risk of non-small-cell lung cancer (NSCLC) and particularly estrogen receptor-positive tumors.

ADVERTISEMENT

Contemporary OB/GYN issue
Stay connected to Contemporary OB/GYN
Receive new issue alerts, technology bulletins, and conference updates!

ADVERTISEMENT

Cervical cancer screening in pregnancy: Impact of the latest ASCCP guidelines (CME)
Placenta accreta, increta, and percreta: Lifesaving strategies to stop the bleeding (Part 2) (CME)
Placenta accreta, increta, and percreta: A team-based approach starts with prevention (Part 1) (CME)
Tamoxifen and raloxifene: Dealing with the side effects (CME)
Depression in pregnancy: When doing nothing is not an option (CME)
New concepts in nongestational acute uterine bleeding (CME)

ADVERTISEMENT

Click here